TrialThe New England journal of medicine2021
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Juan P Frías et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,082 papers cite itlatest 60 shown
this paperpooled ittrialcites it